ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.738,81
-0,72%
S&P 500
5.297,10
-0,21%
Dow Jones
39.869,38
-0,10%
Euro vs US Dollar
1,08582
-0,09%
Bitcoin
65.538,32
0,46%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Ayala Pharmaceuticals Inc (AYLA)

  7. Ayala Pharmaceuticals Inc (AYLA) News

AYLA

Ayala Pharmaceuticals (AYLA)

Ayala Pharmaceuticals Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:AYLA
DatumZeitQuelleÜberschriftSymbolFirma
08/02/202323h17Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:AYLAAyala Pharmaceuticals Inc
06/02/202320h50Edgar (US Regulatory)Schedule 13g
(sc 13g/a)		NASDAQ:AYLAAyala Pharmaceuticals Inc
25/01/202322h54Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AYLAAyala Pharmaceuticals Inc
24/01/202316h22Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AYLAAyala Pharmaceuticals Inc
24/01/202312h07Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:AYLAAyala Pharmaceuticals Inc
24/01/202312h07Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:AYLAAyala Pharmaceuticals Inc
19/01/202321h52Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:AYLAAyala Pharmaceuticals Inc
19/01/202321h44Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:AYLAAyala Pharmaceuticals Inc
19/01/202321h43Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:AYLAAyala Pharmaceuticals Inc
19/01/202321h33Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:AYLAAyala Pharmaceuticals Inc
13/01/202322h02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AYLAAyala Pharmaceuticals Inc
04/01/202323h04Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AYLAAyala Pharmaceuticals Inc
23/11/202222h04Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AYLAAyala Pharmaceuticals Inc
17/11/202222h36Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AYLAAyala Pharmaceuticals Inc
04/11/202221h38Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:AYLAAyala Pharmaceuticals Inc
03/11/202221h08Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:AYLAAyala Pharmaceuticals Inc
19/10/202223h11Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:AYLAAyala Pharmaceuticals Inc
19/10/202223h07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AYLAAyala Pharmaceuticals Inc
11/10/202210h46TipRanksH.C. Wainwright Reaffirms Their Buy Rating on Ayala Pharmaceuticals (AYLA)NASDAQ:AYLAAyala Pharmaceuticals Inc
11/10/202210h45TipRanksNoble Financial Reaffirms Their Hold Rating on Ayala Pharmaceuticals (AYLA)NASDAQ:AYLAAyala Pharmaceuticals Inc
27/09/202216h11TipRanksAyala Pharma (NASDAQ:AYLA) Bags fast Track Status for Desmoid Tumor CandidateNASDAQ:AYLAAyala Pharmaceuticals Inc
27/09/202214h58Dow Jones NewsAyala Pharmaceuticals Gets Fast-Track Designation for AL102 Cancer TreatmentNASDAQ:AYLAAyala Pharmaceuticals Inc
19/09/202212h25TipRanksH.C. Wainwright Sticks to Their Buy Rating for Ayala Pharmaceuticals (AYLA)NASDAQ:AYLAAyala Pharmaceuticals Inc
13/09/202214h05TipRanksAyala Pharmaceuticals (AYLA) Receives a Buy from Noble FinancialNASDAQ:AYLAAyala Pharmaceuticals Inc
12/09/202214h16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AYLAAyala Pharmaceuticals Inc
17/08/202214h05TipRanksNoble Financial Keeps Their Buy Rating on Ayala Pharmaceuticals (AYLA)NASDAQ:AYLAAyala Pharmaceuticals Inc
16/08/202222h40AllPennyStocks.comQ2 Financial Results Send Micro Cap SoaringNASDAQ:AYLAAyala Pharmaceuticals Inc
15/08/202222h21Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:AYLAAyala Pharmaceuticals Inc
27/07/202214h25TipRanksNoble Financial Thinks Ayala Pharmaceuticals’ Stock is Going to RecoverNASDAQ:AYLAAyala Pharmaceuticals Inc
26/07/202220h24TipRanksAyala Pharmaceuticals Stock Nearly Triples on Desmoid Tumor Treatment NewsNASDAQ:AYLAAyala Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:AYLA

Kürzlich von Ihnen besucht

NASDAQ
THRN
Thorne HealthTech
LSE
ASP
African Pioneer
USOTC
OGSAS
Otis Gallery (GM)
BFNX
UDCUSD
USD Coin
LSE
AH36
Citi Fun 25
BIT
UV4L59
UniCredit Bank
LSE
SOLI
Solid State
USOTC
MWRK
Metaworks Platforms (QB)
LSE
RT90
Hsbc Uk Bk 27
EU
D311T
D311T
LSE
AF71
Citi Fun 24
LSE
ZM94
Euro.bk. 41
NASDAQ
FRLAW
Fortune Rise Acquisition
ASX
PRO
Prophecy
TSX
NSCB
NBI Sustainable Canadian...
LSE
59OU
Euro.bk. 55
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten